Patterns and factors influencing oral anticoagulant prescription in people with atrial fibrillation and dementia: Results from UK primary care-Reference-Cited by-同舟云学术

Patterns and factors influencing oral anticoagulant prescription in people with atrial fibrillation and dementia: Results from UK primary care

Published:2020-07-23 Issue:3 Volume:87 Page:1056-1068
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Mongkhon Pajaree¹²³^ORCID,Alwafi Hassan⁴,Fanning Laura⁴⁵,Lau Wallis C.Y.⁴⁶^ORCID,Wei Li⁴,Kongkaew Chuenjid¹⁴,Wong Ian C.K.⁴⁶⁷⁸

Affiliation:

1. Centre for Safety and Quality in Health, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences Naresuan University Thailand

2. Division of Pharmacy Practice, Department of Pharmaceutical Care, School of Pharmaceutical Sciences University of Phayao Phayao Thailand

3. Pharmacoepidemiology and Statistics Research Center (PESRC), Faculty of Pharmacy Chiang Mai University Chiang Mai Thailand

4. Research Department of Practice and Policy, School of Pharmacy University College London London UK

5. Eastern Health Clinical School, Faculty of Medicine, Nursing and Health Sciences Monash University Melbourne Australia

6. Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong

7. Centre for Medication Optimisation Research and Education (CMORE) University College London Hospital UK

8. The University of Hong Kong Shenzhen Hospital Shenzhen Guangdong China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14464

Reference57 articles.

1. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

2. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

3. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study

4. All-cause mortality in 272 186 patients hospitalized with incident atrial fibrillation 1995–2008: a Swedish nationwide long-term case–control study

5. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative effectiveness and safety of direct oral anticoagulants and warfarin in atrial fibrillation patients with dementia;European Stroke Journal;2024-08-30

2. Emulating a target trial to assess effect modification: an application to obesity in the comparative effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation using electronic health records;2023-10-13

3. Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal;Europace;2023-08-02

4. Factors associated with oral anticoagulant prescription status among patients with a new diagnosis of atrial fibrillation;Clinical Cardiology;2023-07-04

5. Anticoagulant use in older persons at risk for falls: therapeutic dilemmas—a clinical review;European Geriatric Medicine;2023-07-01